|
|
Office Locations:
|
320 Park Avenue, 33rd Floor
New York, NY 10022
Phone: 212-887-2105
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
WindRose Health Investors manages over $1.2 billion of capital dedicated to healthcare private equity. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. Target sectors include: Outsourced payor services; Revenue cycle management; Staffing services; Technology enabled solutions; Outsourced clinical services; Healthcare providers; Outsourced pharma services; Behavioral health; and Managed care. The firm pursues investments in businesses of various sizes ranging from $25 million to $300 million in enterprise value. WindRose Health Investors will not invest in companies that have venture-stage risks or unprofitable business models. WindRose targets companies headquartered across the United States and selectively overseas. WindRose Health Investors is comfortable pursuing investments through a range of transaction structures including buyouts, recapitalizations, corporate carve-outs and growth equity investments. Collectively the team has over 80 years of combined experience working with healthcare companies.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
